A novel protocol to reduce bleeding associated with alteplase treatment of HVAD pump thrombosis.
Int J Artif Organs
; 45(2): 231-234, 2022 Feb.
Article
em En
| MEDLINE
| ID: mdl-33596706
ABSTRACT
Pump thrombosis remains a feared complication for patients implanted with durable left ventricular assist devices. Optimal treatment is unknown, but consists of either pharmacologic fibrinolysis or surgical pump exchange. Fibrinolysis is less invasive, but carries a significant risk of intracerebral hemorrhage. We present four cases of LVAD pump thrombosis successfully treated with a novel protocol that consists of low-dose four-factor prothrombin complex concentrate to reverse baseline INR elevation prior to alteplase administration to minimize the risk for intracerebral hemorrhage.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Trombose
/
Coração Auxiliar
/
Insuficiência Cardíaca
Tipo de estudo:
Guideline
/
Observational_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Int J Artif Organs
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Estados Unidos